CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P79
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Margolin, Kim
Wong, Hing C
Morishima, Chihiro
Hernandez, Liza
Ernstoff, Marc
Rhode, Peter R
Waldmann, Thomas A
Article History
First Online: 6 November 2014